Mas-related gene X2 receptor antagonists
A German university offers a new drug target for inflammatory and other diseases related to the mas-related gene X2 (MRGX2) receptor. It will find application in treating pain conditions that involve mast cells, such as skin itching and pain. Related illnesses may be included. Industrial partners are sought for license agreements.